We succeeded in the mass production of stem cells using 3D organoid culture technology. Utilizing this feat, we are currently in the process of developing personalized cell therapy using various types of stem cells.
We culture various types of cancer cells using the 3D organoid culture technique to use for drug screening and modeling of the cancer organ.
Production of cancer clone organs through the culture and injection of cancer cells cultured using 3D organoids.
Cancer clone organs can be used as a disease model for anticancer drug selection, drug combination assessment, biomarker detection, and drug mechanism research.
Evaluation of the activation of various anticancer drugs using patient-derived 3D organoids to select the most effective treatment method.
A combination of drugs is used in chemotherapy, rather than a single drug. To recreate this process, we combine various anticancer drugs to increase the accuracy of our treatment effectiveness assessment.
Mass-produced stem cells using 3D organoids are injected back into the patient to stimulate self-renewal.
Culture and transplantation of cells that comprise the microenvironment surrounding the stem cells to enhance cell growth within the organ.